Paul Sondel
Research Director · University of Wisconsin School of Medicine and Public Health
Credentials: · · ·
History
PresentResearch · St Jude Children's Research Hospital
Research
Graft-versus-leukemia reactions after bone marrow transplantation
Blood · 1990 · 2,389 citations
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
New England Journal of Medicine · 2010 · 1,404 citations
Differential function of major histocompatibility complex antigens in T-lymphocyte activation
Review · Nature · 1976 · Last of 3 authors · 563 citations
40 papers · 5 as a fellow
34 papers · 2 as a resident
- FB
30 papers
- PK
24 papers · 23 as a resident
23 papers · 1 as a fellow
17 papers
17 papers
16 papers · 7 as a resident
Grants
- 2020–2026
National Cancer Institute · P01
Project lead · $1.6M · University of Wisconsin-Madison
- 2018–2024
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
National Cancer Institute · U54
Project lead · $93.8K · Children's Hosp of Philadelphia
- 2015–2023
Enhancing Antibody-Directed Innate Immunity to Improve Cancer Outcome
National Cancer Institute · R35
Contact PI · $6.4M · University of Wisconsin-Madison
- 1982–2015
Clinical Development of HU14.18-IL2 Targeted Therapy
National Cancer Institute · R01
Contact PI · $6.7M · University of Wisconsin-Madison
Clinical trials
- 2020–2025
IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma
Principal investigator · Terminated · Phase 1, Phase 2
University of Wisconsin, Madison
- 2007–2018
Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma
Principal investigator · Completed · Phase 2
University of Wisconsin, Madison
- 2005–2012
Study chair · Completed · Phase 2
Children's Oncology Group
- 2001–2005
Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
Study chair · Completed · Phase 1
Children's Oncology Group